Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kara C Long Roche

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
JAMA Surgery|February 14, 2024
Salpingectomy and Ovarian Cancer Prevention-ReplyRyan M Kahn, Rebecca L Stone, Kara C Long Roche
Cancer|March 24, 2017
Risk-reducing salpingectomy: Let us be opportunisticKara C Long Roche, Nadeem R Abu-Rustum, Mlica Nourmoussavi, et al.
JAMA Surgery|September 6, 2023
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic ReviewRyan M Kahn, Sushmita Gordhandas, Kendra Godwin, et al.
Gynecologic Oncology|October 20, 2018
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancerEdward J Tanner, Olga T Filippova, Ginger J Gardner, et al.
Gynecologic Oncology|September 11, 2017
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancerRenee A Cowan, Jill Tseng, Vijayashree Murthy, et al.
Journal of Surgical Oncology|July 16, 2021
Clinical outcomes of patients with endometrioid epithelial ovarian cancer following surgical treatmentPaulina Cybulska, Jill Tseng, Qin C Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2015
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancerRudy S Suidan, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|April 2, 2018
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume centerRenee A Cowan, Jill Tseng, Narisha Ali, et al.
Gynecologic Oncology|July 22, 2014
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancerRudy S Suidan, Caryn M St Clair, Stephen J Lee, et al.
Gynecologic Oncology|June 4, 2015
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancerRudy S Suidan, Mario M Leitao, Oliver Zivanovic, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
JAMA Surgery|February 14, 2024
Salpingectomy and Ovarian Cancer Prevention-ReplyRyan M Kahn, Rebecca L Stone, Kara C Long Roche
Cancer|March 24, 2017
Risk-reducing salpingectomy: Let us be opportunisticKara C Long Roche, Nadeem R Abu-Rustum, Mlica Nourmoussavi, et al.
JAMA Surgery|September 6, 2023
Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic ReviewRyan M Kahn, Sushmita Gordhandas, Kendra Godwin, et al.
Gynecologic Oncology|October 20, 2018
A prospective trial of acute normovolemic hemodilution in patients undergoing primary cytoreductive surgery for advanced ovarian cancerEdward J Tanner, Olga T Filippova, Ginger J Gardner, et al.
Gynecologic Oncology|September 11, 2017
Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancerRenee A Cowan, Jill Tseng, Vijayashree Murthy, et al.
Journal of Surgical Oncology|July 16, 2021
Clinical outcomes of patients with endometrioid epithelial ovarian cancer following surgical treatmentPaulina Cybulska, Jill Tseng, Qin C Zhou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 10, 2015
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancerRudy S Suidan, Qin Zhou, Alexia Iasonos, et al.
Gynecologic Oncology|April 2, 2018
Exploring the impact of income and race on survival for women with advanced ovarian cancer undergoing primary debulking surgery at a high-volume centerRenee A Cowan, Jill Tseng, Narisha Ali, et al.
Gynecologic Oncology|July 22, 2014
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancerRudy S Suidan, Caryn M St Clair, Stephen J Lee, et al.
Gynecologic Oncology|June 4, 2015
Predictive value of the Age-Adjusted Charlson Comorbidity Index on perioperative complications and survival in patients undergoing primary debulking surgery for advanced epithelial ovarian cancerRudy S Suidan, Mario M Leitao, Oliver Zivanovic, et al.
Pageof 2